RxDoctor Payments Data

Robert Bohinski, PhD

Neurological Surgery · Cincinnati, OHNPI 1306876172

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Medtronic at 50.6% of the total. Reporting peaked in 2021 at $461 and has fallen 95.9% since, to $19 in 2025. That places this record below the midpoint for neurological surgery clinicians in OH, where the typical reported total is $2,744.

$1,280in general payments, 2019–2025

Across 19 payments — averaging $67.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$648
  • Johnson & Johnson$300
  • Globus Medical$167
  • Innovasis Inc$45
  • Zimvie Inc.$23
  • Boston Scientific$22
  • plus $74 from 4 others
$87,946in research payments, 2019–2025

Across 8 payments — averaging $10,993 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$88K

What the payments were for

  • Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,280 in reported general payments places this provider in the 35th percentile of 301 neurological surgery providers in Ohio.

See all neurological surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$486,690
Medicare patients
575
Services billed
2,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin150$2,261
Methylprednisolone70$1,332
Methocarbamol42$732
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$692
Vitamin D2Ergocalciferol (Vitamin D2)34$445
Diclofenac Sodium53$401
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$142
Pregabalin17$107
Oxycodone Hcl13$88
Meloxicam19$63

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →